Pre-and postsynaptic adenosine 5'-triphosphate-sensitive potassium (ATP-K+) currents were studied using whole-cell recordings from substantia nigra zona compacta "principal" neurons in midbrain slices. The GABA, and GABA, receptor-mediated synaptic potentials were unaffected by the ATP-K+ channel inhibitor glibenclamide (30 PM) or by the opener diazoxide (500 PM), indicating that ATP-K+ channels on GABA-ergic terminals are not active, nor can they be activated pharmacologically, under control conditions. However, application of a glucose-free solution to reduce intracellular ATP levels caused a reduction of the GABA, IPSP in all neurons. This was substantially reversed by the sulfonylurea inhibitor tolbutamide (300 PM) in 50% of the neurons tested. The reduction of the GABA, IPSP was a presynaptic effect since postsynaptic hyperpolarizations induced by'the GABA, receptor agonist baclofen (10 PM) were unaffected by glucose-free solutions. Diazoxide (500 PM) induced a slowly developing hyperpolarization or outward current in 64% of principal neurons, which was tolbutamide-(100-300 PM) or glibenclamide-(30 PM) sensitive.
In contrast, the GABA, receptor agonist baclofen (30 PM) induced a rapid hyperpolarization or outward current in all neurons tested that was unaffected by tolbutamide (300 PM). Although both the diazoxide-induced current and the baclofen-induced current were inhibited by Ba*+ (300 PM), the currents elicited by diazoxide and baclofen summated.
The reversal potential for the diazoxide-induced current was also less negative than that for baclofen, which was close to &. In the presence of intracellular cesium, diazoxide induced a tolbutamide-sensitive inward current in a proportion of neurons, indicating that it has other actions in addition to activating a potassium current. Our results suggest that functional ATP-K+ channels exist both pre-and postsynaptically in the SN, where they modulate the activity of principal neurons. They are different to the potassium channels activated by the GABA, receptor agonist baclofen.
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The substantia nigra (SN) contains a high density of high-affinity, tritiated-'H-glibenclamide binding sites (Mourre et al., 1989 (Mourre et al., , 1990 Treherne and Ashford, 1991) . By combining receptor autoradiography and specific neuronal lesions, we have shown that these binding sites are located primarily on striatonigral terminals in SN zona reticulata (Hicks et al., 1994a) . Glibenclamide and other sulfonylureas inhibit ATP-K+ channels (for review see Edwards and Weston, 1993) , so the presence of high-affinity 3H-glibenclamide binding sites has generally been assumed to indicate the presence of ATP-K+ channels. However, this may not be entirely correct. Evidence from insulin-secreting cell lines suggests that sulfonylurea receptors and ATP-K+ channels can exist as independent proteins (Khan et al., 1993) requiring MgZ+ to interact (Lee et al., 1994) . Furthermore, sulfonylurea drugs have been shown to inhibit other types of K+ channels (Reeve et al., 1992; Crepe1 et al., 1993) . Thus, in order to identify ATP-K+ channels unequivocally, it is essential that autoradiographical results are confirmed by functional studies examining the characteristic pharmacological responses of ATP-K+ channels to channel activators such as diazoxide and to sulfonylurea inhibitors.
Both pre-and postsynaptic ATP-K+ channels have been described previously in SN. Biochemical studies suggested that the release of the inhibitory neurotransmitter y-aminobutyric acid (GABA) from terminals within the SN may be under the control of ATP-K+ channels Schmid-Antomarchi et al., 1990) . However, neurochemical studies cannot discriminate between GABA release from intrinsic, inhibitory interneurons and release from striatonigral terminals, nor can it discriminate between GABA released onto GABA, receptors from that released onto GABA, receptors.
SN zona compacta neurons exhibit a postsynaptic hyperpolarization following reduction of intracellular ATP (Hausser et al., 1991; Roper and Ashcroft, 1993) , metabolic poisoning (Roper and Ashcroft, 1993) or application of glucose-free solutions (Roper et al., 1990a) . Diazoxide activates ATP-K+ channels in SN zona reticulata neurons (Schwanstecher and Panten, 1993) , although another ATP-K+ channel opener, levcromakalim, is without effect on zona compacta neurons (Hicks and Henderson, 1992 ; but see also Hausser et al., 1991) . Single ATP-K+ channels of 65pS conductance have been recorded from dissociated SN neurons (Roper et al., 1990a) and of 71pS in reticulata neurons (Schwanstecher and Panten, 1993) .
The superfamily of inhibitory G protein-coupled receptors, which includes GABA,, and dopamine D, receptors, are coupled to an inwardly rectifying potassium channel (I,(,,,, North, 1989) . When two or more of these receptor types are present in the same neuron, they activate the same set of potassium channels (North and Williams 1985) . It has previously been postulated that the ATP-K+ channel is also activated by this superfamily of receptors, since the channel appeared to be coupled to GA-BA, and dopamine D, receptors (Riiper et al., 1990b) . However, this finding has been disputed (Hicks and Henderson, 1992) .
We have used the whole-cell patch clamp technique to determine whether diazoxide can activate pre-and/or postsynaptic ATP-K+ channels in the SN, i.e., ATP-K+ channels located either on GABA-ergic nerve terminals innervating SN zona compacta neurons, or on the compacta neurons themselves. We also compared the postsynaptic actions of diazoxide and the GA-BA, receptor agonist baclofen in order to determine if they are coupled to the same potassium channels.
Preliminary accounts of these results have been presented (Hicks et al., 1994b; Watts et al., 1994) .
Materials and Methods
Tissue preparation. Male Wistar rats (14-28 d postnatal) were killed by a blow to the thorax and cervical dislocation. The scalp and skull were removed and the brain excised. A block of tissue containing the substantia nigra was mounted caudal surface uppermost, in the chamber of a Vibratome containing ice-cold artificial cerebrospinal fluid (ACSF). Coronal sections, 400 km thick, were cut through the caudorostral extent of the SN and stored in oxygenated ACSF at room temperature until used. Slices were cut in half down the midline and a half-slice was placed in the recording chamber (volume 500 pl), held in place by a nylon mesh and perfused with oxygenated ACSF at 3O"C, flowing at 2 mllmin. This solution contained (mM) NaCl 126, KC1 2.5, NaH,PO, 1.24, MgCl, 1.3, CaCl, 2.4, NaHCO, 26, glucose 10, saturated with 95% 0,/5% co,.
Whole-cell recording. The slice was viewed under a dissection microscope, with illumination from below, which allowed identification of the SN zona compacta as a semilucent band between the less luminescent SN zona reticulata and the dark fibers of the medial lemniscus. Whole-cell recordings were made with electrodes that were not fire polished or coated with Sylgard. Pipettes were filled with a solution of the following composition (mu); K gluconate 140, MgCl, 2, CaCl, 1, ethylene glycol-bis(P-aminoethylether)N,N,N',N'-tetraacetic acid (EGTA) 10, K,ATP 0.1 or 2; NaGTP 0.1, HEPES 10, pH 7.3 with KOH. For experiments using cesium as the major cation, K-gluconate was replaced with Cs gluconate or CsCl, and pH adjusted with CsOH. Where CsCl electrodes were used, bicuculline methiodide (BMI; 30 FM) was added to the bathing solution to suppress the large inward currents due to spontaneous IPSCs. Adenosine 5' diphosphate (ADR 0.1 mM) and guanosine 5' diphosphate (GDP; 0.1 mM) were also added to the pipette solution in some experiments. Gluconate ions produced a tip potential of 5-6 mV, which has been accounted for in the results presented. Electrode resistance was 5-6 MR when filled with this solution and intracellular free Ca*+ concentration was calculated to be approximately 10 nM. Electrodes were guided visually into the region of the SN zona compacta and whole>ell recordings made using the "blind-patch" method as described ureviouslv (Hicks and Henderson, 1992) . Membrane potential or voliage clamp recordings were made using an Axoclamp 2A or Axopatch 1B amplifier, respectively, and recorded on chart paper, analog tape, and computer @CLAMP or DEMPSTER programs) for subsequent analysis.
Synaptic potentials. Bipolar stimulating electrodes (Teflon-coated platinum/iridium wire with tip diameter 0.05 mm) were placed in the slice in the ventrolateral half of the SN zona reticulata (approximately perpendicular to the medial lemniscus), and square wave constant-voltage pulses (0.1-0.3 msec duration) were applied. To evoke GABA, receotor-mediated svnantic ootentials, repeated pulses (lo-100 Hz) were applied in trams bf li)O-200 msec-duration at 0.015 Hz. The amplitude and duration of the pulses were adjusted to give submaximal (60-70%) synaptic responses.
Intracellular levels of ATP. The resting level of intracellular ATP is thought to be in the millimolar range, so that ATP-K+ channels are strongly inhibited under normal cellular conditions (Ohno-Shosaku and Yamamoto, 1992) . The ability of diazoxide and sulfonylurea drugs to bind to the ATP-K+ receptor depends on the level of intracellular ATP (Schwanstecher et al., 1991) . Diazoxide opens ATP-K+ channels in the presence of 0.3 mM ATP, but is ineffective with 5 mu ATP (Trube et al., 1986) . Thus, the interaction between intracellular nucleotides and drugs acting at the ATP-K+ channel may be an important factor in determining the effectiveness of drugs applied to modulate this channel. Therefore, for the study of presynaptic ATP-K+ channels, 2 mM ATP was used in the pipette solution in an attempt to minimize any effects of diazoxide or glucose-free solutions on the postsynaptic neurons, whereas for the postsynaptic studies, 0.1 mM intracellular ATP was used in the pipette solution in an attempt to lower intracellular ATP and, thus, maximize the possible postsynaptic effects of diazoxide. In addition, guanosine 5' triphosphate (GTP, 0.1 mM) was included in the pipette solution to facilitate G-protein activation since activation of ATP-K+ channels may involve G-protein coupling (Zini et al., 1993; Terzic et al., 1994) .
Drugs. Drugs were applied by superfusion; complete exchange of the solution in the recording chamber took 2 min. The drugs used were 6-cyano-7.nitroquinxaline-2,3-dione (CNQX), D-2-amino-5-phosphonovaleric acid (AP5), and 2-hydroxy saclofen (gifts of Tocris Neuramin, UK), ( +)-baclofen (Research Biochemicals, Inc.), bicuculline methiodide, diazoxide, glibenclamide, and tolbutamide (Sigma, UK). Stock solutions (10 mM or 100 mM) of the excitatory amino acid and GABA receptor ligands were prepared in distilled water and stored at 4°C [except CNQX, which was dissolved in either dimethyl sulfoxide (DMSO) or 0.1 M NaOH]. Other drugs were prepared daily from solid and stored at 4°C until used. Diazoxide and tolbutamide were prepared as 100 mM solutions in 0.3 M NaOH. When diluting these to give the final concentration of drug in the bathing solution, an equal volume of 0.3 M HCl was added to the ACSF to compensate the small change in pH, a procedure that resulted in insignificant changes in the concentration of NaCl in the ACSE Glibenclamide was prepared as a 10 mM solution in 5% DMSO and 20 mu NaOH, and no pH compensation was made.
Statistics. Numerical data are expressed as the mean 2 standard error of the mean. Statistics cited represent the p value gained using a Student's t test for paired or unpaired data. Differences were considered significant if p < 0.05.
Results

IdentiJcation of principal neurons
Whole-cell recordings were made from a total of 104 neurons in the SN zona compacta, which had electrophysiological characteristics similar to those described previously for nigral neurons in in vitro midbrain slice preparations (Lacey et al., 1989; Yung et al., 1991; Nedergaard and Greenfield, 1992) . The majority of neurons observed (85%) had the characteristics of "principal neurons" and are presumed to be the dopaminergic neurons that are located within the SN zona compacta and form the major part of the nigrostriatal pathway. Other neurons with the previously described "secondary"
and "phasic" characteristics were also observed but were not included in this report.
Characterization of synaptic inputs
To examine evoked synaptic potentials, postsynaptic neurons were hyperpolarized to membrane potentials between -55 and -70 mV by injection of negative direct current. This resulted in cessation of spontaneous action potential firing, and subsequent evoked synaptic responses were subthreshold for action potential initiation.
Single-pulse stimulation within the zona reticulata produced a fast compound synaptic response. In some neurons, this consisted of both depolarizing and hyperpolarizing phases. In others, the response was almost purely depolarizing or purely hyperpolarizing.
In the majority of neurons, the compound synaptic response was made up of three superimposed components. These could be distinguished pharmacologically as AMPA-, NMDA-, and GABA,-receptor-mediated synaptic potentials by the addition of CNQX (2-10 PM), AP5 (30 PM), and bicuculline (lo-30 FM). The GABA, receptor-mediated inhibitory postsynaptic potential (IPSP) was isolated pharmacologically in 25 neurons. In all neurons tested, the addition of the excitatory amino (10 pm) and AP5 (30 phi), a single stimulus evoked a hyperpolarizing postsynaptic potential. This was mediated by GABA,, receptors since addition of bicuculline (30 ~,I\;I) strongly inhibited the IPSP The effect was partially reversed upon washout. B, Neuron hyperpolarized to -61 mV using direct current injection. A train of stimuli (100 Hz for 100 msec, beginning at the point indicated by the nrronY~rrd) evoked a biphasic hyperpolarizing synaptic response in the presence of CNQX (10 FM) and AP5 (30 F~I). The early phase was inhibited by the subsequent addition of bicuculline (30 pi"~). The remaining stow, long-lasting IPSP was mediated by GABA, receptors as shown by its blockade by the selective GABA,, receptor antagonist CGP 55845A (300 11~4). Stimulus artifacts have been removed to allow a clear view of the IPSP In both A and B. each trace is the average of at least four individual traces of synaptic potentials evoked consecutively in the same neuron. acid receptor antagonists CNQX and AP.5 (10 F~I and 30 pb~, respectively, II = 25) left a single hyperpolarizing component (Fig. IA) . It was in the hyperpolarizing direction since gluconate was the major intracellular anion, and reversed polarity at -83 2 4 mV (mean + SEM, II = 4). The calculated chloride equilibrium potential, E,,, was -81 mV. The kinetic parameters of the GABA, receptor-mediated IPSP were measured in 12 neurons. The mean time to onset was 2.3 + 0.3 msec, the time from onset to peak amplitude was 10.7 + 0.1 msec, and the half time of decay was 47 + 3 msec. The peak amplitude was -6.5 + 0.5 mV. The GABA, IPSP was abolished by bicuculline (30 PM, II = 4; Fig. 1A ). The effects of bicuculline were only partially reversed after washing out the drug for 20 min.
Application of a train of stimuli (see Materials and Methods) in the presence of CNQX (10 p.~) and AP5 (30 p,M) resulted in a biphasic hyperpolarizing synaptic response (n = 29; Fig. 1B ) in which a long duration GABA, IPSP followed the rapid GA-BA, IPSP The GABA,, component of the response could then be isolated from the GABA, component by the addition of bicuculline (30 PM, II = 18). The GABA, IPSP reversed polarity at -106 + 2 mV (n = 3; calculated potassium equilibrium potential, E,, -108 mV). It had a mean time to onset of 81 & 8 msec, a time from onset to peak amplitude of 246 -t 1 1 msec, and a half-time of decay of 355 -t 22 msec. The mean amplitude was -9.2 t 0.8 mV. This slow, long-lasting synaptic potential was inhibited by the GABA,, receptor-selective antagonists 2-hydroxy saclofen (100-300 yr~t, II = 3) or 3-N-[ l-(S)-(3,4-dichlorophenyl)ethyl]amino-2-(s)-hydroxy-propyl-P-benzyl phosphinic acid (CGP 55845A, 300 nbt, II = 1; Fig. 1B ).
The level of ATP in the pipette solution was 2 rnM during this set of experiments.
Dicrzmide. The ATP-K' channel opener diazoxide (500 ~IVI) applied for up to 15 min either produced no change in four of five cells, or a reduction (34% in one of five cells) in the amplitude of the GABA, IPSP, which was not reversed by the ATP-K-channel inhibitor tolbutamide (300 p&t) but did recover upon washout. Similarly, diazoxide (500 kht) produced either no change (in five of six cells) or a tolbutamide-insensitive reduction (40% in one of six cells) in the amplitude of the GABA, receptor-mediated IPSP when applied for up to 15 min. Diazoxide applied for this duration did induce postsynaptic effects (see below). Glibenclamide (30 ~JJ), applied alone for periods of up to 10 min, produced no change in the amplitude or duration of the GABA, (n = 4) or GABA, (n = 5) receptor-mediated IPSPs. Thus, under our standard in vitro brain slice recording conditions the putative presynaptic ATP-K+ channels on GABAergic nerve terminals (Hicks et al., 1994a) do not open (deduced from the lack of effect of the ATP-K+ channel inhibitor glibenclamide) nor could they be opened by diazoxide. Glucose-free solution. One explanation for the lack of effect of diazoxide on GABA-ergic IPSPs is that in the GABA-containing nerve terminals the intracellular ATP concentration was high enough to prevent opening of ATP-K+ channels by diazoxide. In order to reduce the intracellular ATP concentration within the GABA-ergic nerve terminals to levels at which the ATP-K+ channels could open spontaneously, we perfused nigral slices with a glucose-free solution. Removal of glucose from the bathing solution for up to 20 min did not alter the amplitude or duration of the GABA,-mediated IPSP (Fig. 2A) . The mean amplitude of the IPSP was -5.9 t 0.7 mV in the presence of glucose, and -6.0 + 0.7 mV in the absence of glucose (n = 12). In contrast, removal of glucose from the bathing solution for 15-25 min produced a gradual reduction in the amplitude of the GABA,-mediated IPSP from -8.1 & 0.9 mV to -5.6 + 0.9 mV (30.2 +-4.5% reduction, n = 12, p < 0.005, paired t test; Fig. 2B ). The reduction in GABA, IPSP amplitude was fully reversed when glucose was reapplied (-8.6 + 1.5 mV, n = 8). The reduction of GABA, IPSP amplitude would appear to be mediated by a presynaptic reduction in GABA release since (1) it was not associated with any consistent changes in postsynaptic input resistance or membrane potential, and (2) the postsynaptic hyperpolarization produced in principal neurons by bath application of the GABA, receptor agonist baclofen (10 PM, producing 90% of maximum response) was unchanged in the absence of glucose (Fig. 2C) . In 10 neurons the mean hyperpolarization produced by baclofen (10 pM) in the presence of glucose was -11 ? 1 mV, and, on reapplication to the same neurons after superfusion with a glucose-free solution for 15-20 min, it was -10 + 1 mV.
Tolbutamide (300 FM) was tested for its ability to reverse the reduction of the GABA,-mediated IPSP in glucose-free solutions. In six neurons, the inhibition was rapidly reversed by between 31% and 100% (mean reversal of 80 + 1 l%, n = 6; Fig.  2B ). In another six neurons, tolbutamide did not reverse the effect of glucose-free solutions. In these cases, however, the IPSP amplitude returned to control levels when glucose was reapplied. These results show that, although the ATP-K+ channel opener diazoxide is without effect on IPSPs, lowering of ATP levels in synaptic terminals does modulate GABA,-mediated synaptic transmission. In 50% of cases this appears to be by opening ATP-K+ channels on synaptic terminals.
Postsynaptic ATP-K+ channels The effect of diazoxide upon principal neurons was investigated using both voltage clamp and membrane potential recordings. The concentration of ATP in the pipette solution was 0.1 mM, and extracellular glucose was 10 mM. In some experiments, 0.1 mM ADP and GDP were included in the pipette solution, in addition to the standard 0.1 mM ATP and GTP, to provide a supply of nucleotides necessary for G-protein and ATP-K+ channel function. However, responses to diazoxide were comparable either with (n = 7) or without (n = 10) ADP and GDP in the pipette, so data have been combined.
Neurons had an input resistance of 281 + 15 Ma and required injection of -127 ? 8 pA of current to hold them at -65 mV (n = 36). Diazoxide (500 pM) induced an outward current in 17 of 29 neurons under voltage clamp (59%), or a hyperpolarization in 16 of 23 (69%) of neurons in current clamp (overall, 64%). The response developed very slowly over lo-15 min, reaching -5.0 ? 0.5 mV in current clamp (n = 15; Fig. 3A ) or 108 + 18 pA under voltage clamp (n = 17; Fig.  3B ). The diazoxide-induced outward current was accompanied by a fall in input resistance by 33 ? 4% (n = 17). Tolbutamide (100-300 FM) inhibited the outward current by 67 f 8% (n = 7; Fig. 3B ), and the fall in input resistance by 96 ? 10%. Glibenclamide (30 FM) inhibited the diazoxide-induced current by 59 & 10% (n = 9) and the fall in input resistance by 71 + 14%. Tolbutamide (300 PM) had no effect on holding current or input resistance when applied alone (n = 3).
Efect of baclofen in comparison to that of diazoxide The effect of the GABA, receptor agonist baclofen was compared to that of diazoxide in order to determine whether they activate the same set of potassium channels, as reported by Roper et al. (1990b) . In contrast to diazoxide, which was effective in only 64% of neurons, bath application of baclofen (lo-30 PM) induced an outward current, or hyperpolarization, in all neurons tested (n = 21). The baclofen-induced outward current was also much more rapid in onset, and of larger amplitude, than that induced by diazoxide, taking only l-2 min to reach a maximum of 140 t 13 pA (n = 13) or 12 mV (n = 2), under standard recording conditions (Fig. 3C) , with a fall in input resistance of 49 + 4%. In addition, the baclofen-induced current differed from that induced by diazoxide in that it was significantly larger in the presence of intracellular ADP and GDP (237 t 41 pA, n = 6, p < 0.05). The effects of baclofen were fully reversed by washout for 25-30 min or by the GABA,-receptor antagonist 2-hydroxy-saclofen (100-300 pM, n = 3). In contrast, 2-hydroxy-saclofen (300 PM) had no effect on the diazoxideinduced outward current (n = 3; see Fig. 3B ). Also, tolbutamide (100-300 PM) was without effect on the outward current induced by baclofen (n = 4; Fig. 3C ).
Of 20 neurons to which both diazoxide and baclofen were applied sequentially (diazoxide applied first), 9 showed no response to diazoxide. For the 11 neurons that responded to both drugs, current-voltage plots were constructed using the instantaneous current responses evoked by voltage steps from a holding potential of -65 mV. No reversal was apparent for the diazoxide-induced current in four of the neurons, despite the presence of an obvious reversal potential for baclofen in the same neurons (Fig. 4B ). In the other seven neurons, the diazoxide-induced current reversed at -93 + 4 mV, and the baclofeninduced current reversed at -106 ? 4 mV (E, -108 mV; Fig.  4A ). In none of the neurons was the reversal potential for baclofen and diazoxide the same, and in six of the seven neurons the reversal potential for the diazoxide current was less negative than that for baclofen (JJ < 0.05).
The different reversal potentials obtained for diazoxide and baclofen indicate that they may be acting through different sets of ion channels, either (1) of different ionic permeability, or (2) of different location. This was investigated further by determining whether currents induced by maximally effective concentrations of the two drugs were additive (see North and Williams, 1985) . Figure 5A shows a neuron to which both baclofen and diazoxide were applied together, and is representative of four such experiments. The currents evoked by diazoxide and baclo- . Glucose-free solutions inhibited the GABA,, but not the GABA,, IPSP A, SN zona compacta neuron hyperpolarized to -66 mV with direct current injection. In the presence of CNQX (10 PM,) and AP5 (30 PM), a single stimulus evoked a GABA,-mediated IPSP (left), which was unaffected by glucose-free solution (20 min; middle), and remained the same upon reapplication of glucose (right) . B, In the presence of CNQX (10 FM), AP5 (30 PM), and bicuculline (~O~.LM), a train of stimuli evoked a slow hyperpolarization (left). This GABA,-mediated IPSP was reduced by 28% in glucose-free solution (20 min; middle trace) an effect that was fully reversed by tolbutamide (300 PM, right). This neuron is representative of 6 of 12 neurons tested. In the other six neurons, the GABA, reduction was tolbutamide insensitive. Stimulus artifacts have been removed to allow a clear view of the IPSPs. Each trace is an average of four consecutive traces evoked in the same neuron. C, In a SN zona compacta neuron hyperpolarized to -68 mV with direct current injection (-120 PA), a 3 min application of baclofen (10 PM) induced an 11 mV hyperpolarization. After bathing the slice in glucose-free solution for 15 min, -80 pA was required to hold the neuron at -68 mV. The neuron again hyperpolarized 11 mV in response to 10 JLM baclofen. Drugs were applied for the duration of the bars. . Diazoxide induced a hyperpolarization and outward current in SN principal neurons. A, A neuron hyperpolarized to -65 mV with direct current injection slowly hyperpolarized in response to diazoxide (500 FM) and input resistance fell (measured from amplitude of membrane hyperpolarization to 100 msec duration -0.05 pA pulses; downward deflections). The response to diazoxide was reversed by tolbutamide (100 FM). B, SN zona compacta neuron held at -65 mV in voltage clamp; a slowly developing outward current was induced by diazoxide (500 PM), and was reversed by tolbutamide (300 FM). The GABA,-receptor antagonist 2-hydroxy-saclofen (300 pM) was without effect on the diazoxide-induced outward current. C, A different neuron at -65 mV in voltage clamp; a rapidly developing outward current was induced by baclofen (30 FM), which was insensitive to tolbutamide (100 FM).
There was a slow desensitization of the outward current in this neuron during prolonged baclofen application. Drugs were applied for the duration of the bars.
of baclofen is most likely due to receptor desensitization rather than any interaction with the diazoxide since, in another four cells, sequential applications of 30 FM baclofen alone (35 ? 3 min apart) revealed that the outward current induced by the first application of baclofen was 115 f 8% of the second response. These experiments demonstrate that the currents induced by baclofen and diazoxide are additive, and that the two drugs must be acting through different sets of channels.
Baclofen and other agonists of the superfamily of G-proteinlinked receptors activate a barium-sensitive inwardly rectifying potassium channel, IKCIR) (Lacey et al., 1988; Williams et al., 1988; North, 1989) . We investigated whether the diazoxide-activated current also showed barium-sensitivity by applying a low concentration of BaZ+ (300 FM). The baclofen-induced outward current was inhibited by 84 2 7% by application of Ba2+ (n = 3; Fig. 5B ). The diazoxide-induced current was also sensitive, being inhibited by 76 2 3% in the presence of Ba2+ (300 PM, n = 4).
The more positive reversal potential obtained with diazoxide than baclofen could indicate that diazoxide either (1) opens more than one type of channel, one of which is a potassium channel while the other may be selective for other ions, e.g., sodium, calcium, or (2) that the diazoxide-activated ATP-K+ channel is not entirely selective for potassium ions over other cations. To investigate this further, we applied diazoxide to cells that had cesium as the major cation in the pipette solution instead of potassium. This should block potassium channels and reveal if diazoxide has an additional action. Of seven cells, five cells showed no change in holding current in response to diazoxide (500 pM) or tolbutamide (300 FM). The other two cells showed a slowly developing inward current (-20 pA and -40 PA) in response to diazoxide, which was partially (50% in each case) reversed by tolbutamide (300 PM). Input resistance also fell (by 40% and 9% respectively), and was reversed (by 50% and 71%) by tolbutamide.
Discussion
The present study demonstrates the synaptic input to dopaminergic neurons of the SN zona compacta to be mediated by excitatory amino acid (AMPA and NMDA) receptors, and GA-BA, and GABA, receptors. This is in agreement with previous studies (Mereu et al., 1991 (Mereu et al., , 1992 Johnson et al., 1992; Yung and Htiusser, 1993) . In contrast to the 'H-GABA release studies by Amorosso et al. (1990) our electrophysiological study showed no increase in the amplitude of either GABA,-or GA-BA,-mediated IPSPs with the ATP-K+ channel inhibitor glibenclamide. This finding may be interpreted in a number of ways: first, high-affinity jH-glibenclamide binding sites located on striatonigral terminals (Hicks et al., 1994a) may indeed indicate the presence of functional ATP-K' channels, but the channels are closed in the presence of physiological levels of glucose and oxygen. The reduction in the amplitude of the GABA, receptormediated IPSP upon removal of glucose which, in a proportion of neurons was sulfonylurea reversible, indicates that functional ATP-K+ channels are, indeed, present on at least some nigral terminals. However, our results demonstrate that the slice must be metabolically compromised before such channels can open and subsequently be closed by the application of a sulfonylurea ATP-K+ channel inhibitor. It appears that, under our recording conditions, there is sufficient ATP within the terminal to keep the channels closed. Second, it is possible that not all of the high-affinity "H-glibenclamide binding sites on striatonigral terminals are coupled to ATP-K+ channels..There is evidence that ATP-K+ channels and sulfonylurea receptors can exist as independent proteins (Khan et al., 1993) . Functional ATP-K+ channels have been described in an insulinoma cell line that possessed no glibenclamide binding sites (Khan et al., 1993) and sulfonylurea drugs (including glibenclamide and tolbutamide) mV. This avoids any contamination by the slowly developing hyperpolarization-activated cation current, I,,, which is present in these neurons. The current at -65 mV is the holding current. A, Current-voltage relations for baclofen (30 pM, left) and diazoxide (500 pM, right) in a single neuron; the reversal potential for diazoxide was -83 mV. The reversal potential for baclofen was -110 mV. This neuron is representative of 7 of 11 neurons that responded to both diazoxide and baclofen. B, Current-voltage relations for baclofen (30 PM, left) and diazoxide (500 PM, right) in another neuron. There was no intercept for the diazoxide-induced outward current, but an obvious reversal for that induced by baclofen (-108 mV). This neuron is representative of 4 of 11 neurons that responded to both diazoxide and baclofen. Filled triangles are control; jlled circles are at the maximum response to the drug.
have been shown to inhibit a voltage-dependent, ATP-indepentential was affected by removal of glucose lends further support dent potassium channel in hippocampal neurons (Crepe1 et al., to the view that there are discrete inhibitory inputs onto SN zona 1993), and in a neuroblastoma cell line (Reeve et al., 1992) . compacta neurons that are under independent control. We found that glucose-free solutions had a selective effect Although the GABA,-mediated IPSP was reduced in all neuupon the GABA, receptor-mediated IPSP, leaving the GABA,-rons in glucose-free solutions, in half of neurons there was no mediated IPSP unaffected. It has been shown that synaptic inrecovery of the IPSP with tolbutamide. This would indicate that puts to GABA, and GABA, receptors in midbrain dopaminergic the reduction of the IPSP was not always mediated by the openneurons originate from discrete afferent neurons (Johnson et al., ing of sulfonylurea-sensitive ATP-K+ channels. Others have re-1992; Sugita et al., 1992) . Long GABA-containing projection ported that postsynaptic hyperpolarizations caused by anoxia in neurons from striatum preferentially release GABA onto GAdopaminergic neurons are glibenclamide insensitive (Mercuri et BA, receptors, whereas GABA, synaptic potentials result from al., 1994) . These could be mediated by the "nonclassical" ATPthe activity of GABA-ergic neurons intrinsic to the SN. Thus, sensitive nonselective cation channels (ATP-NS) that have been our finding that only the GABA, receptor-mediated synaptic podescribed in cortical and cerebellar neurons (Ashford et al., 1988; Ohno-Shosaku and Yamamoto, 1992) . Their sensitivity to sulfonylurea drugs was not reported. SN zona compacta principal neurons hyperpolarize in response to diazoxide but not to another ATP-K+ channel opener, levcromakalim, at concentrations up to 500 FM (Hicks and Henderson, 1992 ; but see also Hausser et al., 1991) . This difference may reflect a differential sensitivity to channel openers that has been described for other tissues (Edwards and Weston, 1993) . SN zona compacta neurons would appear to have a similar pharmacology to the pancreatic p cell, in which diazoxide (100 PM) inhibited insulin release by more than 90% but levcromakalim (500 pM) inhibited release by only 35% (see Edwards and Weston, 1993) . Diazoxide produced an outward current in only a proportion of zona compacta principal neurons, in contrast to baclofen, which was effective in all neurons. The response to diazoxide was also variable, and was smaller than the baclofen response. This suggests that individual SN zona compacta neurons may exhibit differing levels of ATP-K+ channel expression, and that some neurons may not express ATP-K+ channels at all.
Ohno-Shosaku and Yamamoto (1992) also found that diazoxide was ineffective in 50% of neurons in cultured rat neocortical and hippocampal neurons. Roper and Ashcroft (1993) did not report the percentage of SN neurons that responded to reduced intracellular ATP An alternative explanation for the lack of response to diazoxide in some neurons is that it may not be able to activate all the ATP-K+ channels. For example, it may not be reaching its binding site on the intracellular side of the membrane in some neurons. We have attempted to apply diazoxide intracellularly by including it in the pipette solution at 100-500 pM.
However, no outward current developed within 15-30 min of patch rupture, although subsequent bath application of 500 p.M diazoxide to the same neuron did induce an outward current. The protocol has not been pursued due to the great difficulty in gaining recordings when diazoxide was included in the pipette.
Diazoxide has a pKa of 8.5, so that during bath application at physiological pH, more than 90% of the diazoxide applied is in the unionized, membrane permeable, form. Thus, it may be "mopped up" by the high level of lipid in brain tissue and, consequently, unable to reach more deeply located neurons. However, diazoxide was applied to the bath at a very high concentration (500 PM). If diazoxide was reaching its site of action in all neurons, then another possible explanation for the highly variable responses might be that the naturally high (ITIM) levels of intracellular ATP in neurons inhibited the effect of diazoxide (Trube et al., 1986) .
The inclusion of ADP and GDP in the pipette solution did not affect the response to diazoxide. This could indicate either that the diazoxide effect is independent of phosphorylation processes, or else an inability to dialyze ADP and GDP to distant parts of the dendritic tree. The baclofen-induced current was larger in the presence of ADP and GDP than in their absence, becoming similar in amplitude to that reported using "sharp" microelectrodes (Lacey et al., 1988) . This indicates that ADP and GDP are required for full activation of the GABA, receptoractivated channels, and that endogenous ADP and GDP were dialyzed out of at least the proximal part of the neuron during whole-cell recording when they were not included in the pipette solution.
In neurons that did respond to diazoxide, the reversal potential was found to be slightly less negative than that for the baclofeninduced current and the calculated E, in these neurons. This indicates that the diazoxide-evoked current is either (1) through a channel that is not purely selective for potassium-possibly similar to the novel "nonclassical" ATP-sensitive nonselective cation channel (ATP-NS) described in cortical neurons (Ashford et al., 1988; Ohno-Shosaku and Yamamoto, 1992) , or (2) diazoxide activates more than one type of channel in SN zona compacta neurons, each with a different reversal potential. These possibilities are not mutually exclusive. Diazoxide may open the "classical" ATP-K+ channel, but may also open one or more other channels to some extent, such as the ATP-NS channel. Our experiments using cesium in the pipette provide support for the hypothesis that diazoxide opens more than one type of channel. The outward current induced by diazoxide was barium sensitive, showing that it was due to activation of the inward rectifying potassium channel. However, when potassium channels were blocked by intracellular cesium, diazoxide induced a small tolbutamide-sensitive inward current and fall in input resistance in a proportion of cells. The data do not provide conclusive evidence as to the ion(s) involved in this response but are consistent with the activation of an ATP-NS current. After prolonged glucose-free periods, neurons often suddenly went into a paroxysmal depolarization from which they sometimes recovered following reapplication of glucose (Watts and Hicks, unpublished observations) . Neurons show a biphasic response to ischemia, hypoxia, or anoxia, with an initial hyperpolarization due to potassium channel activation followed by sudden depolarization due to nonselective ion movement (Hansen, 1985; Rijper and Ashcroft, personal communication) . Thus, it appears that ATP-NS channels may well be present on these neurons, but that intracellular ATP levels must be exhausted before these channels open spontaneously.
Despite the similar sensitivity of the diazoxide-and baclofeninduced outward currents to blockade by Ba2+, the difference in their reversal potentials and the lack of effect of tolbutamide on the baclofen-induced current indicated that diazoxide and baclofen activated different sets of channels. Further investigation showed that the currents induced by diazoxide and baclofen were additive, strongly supporting this hypothesis. If the two drugs were activating the same potassium channels, then it would be expected that a maximally effective concentration of baclofen when applied in concert with diazoxide would induce a smaller current than when applied alone (North and Williams, 1985) . Riiper et al. (1990b) suggested that dopamine D, receptors and GABA, receptors activated ATP-K+ channels. However, we found no evidence for activation of ATP-K+ channels by dopamine (Hicks and Henderson, 1992) , although a novel subtype of ATP-K+ channel recently described in corpus striaturn may be modulated by quinpirole, an agonist at D,, D,, and D, receptors (Lin et al., 1994) . In the present study, we demonstrated that the diazoxide-activated channels are distinct from those opened by baclofen, and that the ATP-K+ channel is not activated by the superfamily of inhibitory G-protein-linked receptors.
The striatonigral input has a major inhibitory influence on the SN. Our results demonstrate that in times of metabolic stress, such as occurs in periods of anoxia and ischemia, ATP-K+ channels on striatonigral terminals may become active due to reduced intraterminal levels of ATP. The resulting hyperpolarization of the terminal leads to a reduction of GABA release. It is difficult to reconcile the disinhibition of SN zona compacta neurons that would result from the reduced GABA release, with the suppressant effects of ATP-K+ channel activation postsynaptically. Perhaps a more subtle effect on dopaminergic neuron activity is afforded by the pre-and postsynaptic responses in concert. It is possible that the postsynaptic hyperpolarization required to prevent the damaging effects of anoxia and ischemia on the nigral neuron would lead to an upset of the tiormal interaction of these neurons with other CNS regions. By reducing the inhibitory synaptic input onto SN zona compacta neurons at this time, the neurons may be protected from damage while retaining a reasonably normal pattern of activity.
